Amispiron (fenspirid hydrochloride) ІS tablets with prolonged release 0.08g. №10

$3.30

Manufacturer: Ukraine

Purpose: Blocks histamine receptors, used for bronchial asthma and chronic bronchitis.

Out of stock

SKU: MED56423 Category:

Description

Amispiron (fenspirid hydrochloride) ІS tablets with prolonged release 0.08g. №10

Ingredients

Each tablet contains 0.08g of fenspirid hydrochloride.

Dosage

The recommended dosage is one tablet daily. It is important to follow the instructions provided by your healthcare provider.

Indications

Amispiron tablets are indicated for the treatment of respiratory conditions such as bronchitis and asthma. They help in reducing inflammation and improving breathing.

Contraindications

Do not use Amispiron tablets if you are allergic to fenspirid hydrochloride or any other ingredients in the product. Consult your doctor before starting this medication.

Directions

Take the tablet with a full glass of water, with or without food. Do not crush or chew the tablet. If you miss a dose, take it as soon as you remember.

Scientific Evidence

Fenspirid hydrochloride, the active ingredient in Amispiron tablets, has been studied for its bronchodilator and anti-inflammatory properties. Research published in the Journal of International Medical Research has shown that fenspirid can effectively improve lung function and reduce symptoms in patients with chronic respiratory conditions.

Additional Information

It is important to note that Amispiron tablets with prolonged release provide a steady level of medication in the body, offering prolonged relief from respiratory symptoms. Always consult your healthcare provider before starting any new medication.

Pharmacological Effects: Fenspirid hydrochloride acts by inhibiting the release of inflammatory mediators and improving bronchial obstruction. It also helps in reducing mucus production, making it easier to breathe.

Clinical Trials: Clinical trials have demonstrated the effectiveness of fenspirid hydrochloride in improving lung function and reducing the frequency of exacerbations in patients with chronic respiratory diseases. A study published in the European Respiratory Journal showed significant improvements in lung function and quality of life in patients treated with fenspirid.